Encompass Health CFO Coltharp sells $5 million in stock

Douglas E. Coltharp, Executive Vice President and Chief Financial Officer of Encompass Health Corp (NYSE:EHC), recently executed significant stock transactions as reported in an SEC filing. On April 29, Coltharp sold a total of 43,575 shares of Encompass Health common stock, generating approximately $5,017,537. The shares were sold at prices ranging from $114.78 to $116.36 per share, near the stock’s 52-week high of $117.52. According to InvestingPro data, EHC has shown strong momentum with a 15% gain in the past week and is currently trading above its Fair Value.

In addition to these sales, Coltharp exercised options to acquire 43,575 shares at prices between $29.06 and $32.94 per share. After these transactions, Coltharp holds 60,335 shares directly, with additional shares held indirectly through a trust and by his spouse.

These transactions are part of Coltharp’s ongoing management of his holdings in the company.

In other recent news, Encompass Health Corp has reported impressive financial results for the first quarter of 2025, surpassing analyst expectations. The company’s earnings per share (EPS) came in at $1.37, exceeding the forecasted $1.20, while revenue reached $1.46 billion against a projected $1.43 billion. This strong performance prompted Encompass Health to raise its full-year guidance, projecting higher net operating revenue and EPS. Following these results, Mizuho (NYSE:MFG) Securities increased its price target for Encompass Health to $130, maintaining an Outperform rating, citing robust patient volumes and effective expense management. Similarly, RBC Capital Markets raised its price target to $125, also keeping an Outperform rating, and noted the positive shift in payer mix with Medicare Fee-For-Service volumes surpassing Medicare Advantage for the first time in three years. The company has also announced strategic expansions, including new hospitals and bed additions, to meet growing demand. These developments underscore Encompass Health’s strong market position and the confidence analysts have in its future growth prospects.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.